Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

摘要

Compounds of formula (I) wherein R<1>, HET-1 and HET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.